MTOR and cancer: In contrast, our findings indicate that ArcA exhibits cancer-specific cytotoxicity and anti-metastatic activity in vitro, with GSK-3β dephosphorylation at Ser9, a process negatively regulated by MAP kinase and PI3K-AKT-mTOR signaling [19].